Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.
Mahil, SK
; Yiu, ZZN; Mason, KJ; Dand, N; Coker, B; Wall, D; Fletcher, G; Bosma, A; Capon, F; Iversen, L; +13 more...Langan, SM; Di Meglio, P; Musters, AH; Prieto-Merino, D; Tsakok, T; Warren, RB; Flohr, C; Spuls, PI; Griffiths, CEM; Barker, J; Irvine, AD; Smith, CH; and Secure-AD and PsoProtect study groups
(2020)
Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.
British Journal of Dermatology, 183 (2).
pp. 404-406.
ISSN 0007-0963
DOI: 10.1111/bjd.19161
; Yiu, ZZN; Mason, KJ; Dand, N; Coker, B; Wall, D; Fletcher, G; Bosma, A; Capon, F; Iversen, L; +13 more...Langan, SM; Di Meglio, P; Musters, AH; Prieto-Merino, D; Tsakok, T; Warren, RB; Flohr, C; Spuls, PI; Griffiths, CEM; Barker, J; Irvine, AD; Smith, CH; and Secure-AD and PsoProtect study groups
(2020)
Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.
British Journal of Dermatology, 183 (2).
pp. 404-406.
ISSN 0007-0963
DOI: 10.1111/bjd.19161
We wish to bring your attention to the PsoPROTECT (Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of Covid-19 infecTion) and SECURE-AD (Surveillance Epidemiology of Coronavirus Under Research Exclusion-Atopic Dermatitis) registries; two urgent global initiatives that address an unmet need for delineating the determinants of COVID-19 outcomes in the common cutaneous immune-mediated inflammatory diseases (IMIDs) psoriasis and atopic dermatitis.
-
picture_as_pdf - bjd.19161.pdf
-
subject - Accepted Version
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 3.0
Downloads